photo of Prof Franz Babl

Prof Franz Babl

Prof Franz Babl

Details

Role Group Leader / Principal Research Fellow
Research area Clinical sciences
Professor Franz Babl is the Group Leader of Emergency Research at the Murdoch Children's Research Institute and the Professor of Paediatric Emergency Medicine at the University of Melbourne. He works as a paediatric emergency physician at The Royal Children's Hospital. He studied in Germany, the United Kingdom and the United States of America and trained in the USA as a paediatrician, emergency physician and infectious diseases physician.

He was the co-founder and founding chair of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network in Australia and New Zealand, and a current member of the executive committee. This network involves all major tertiary paediatric hospitals in Australia and New Zealand, with an annual census of half a million paediatric presentations. This collaboration is uniquely placed to conduct multicentre trials.

Professor Babl has conducted many collaborative studies with the PREDICT network. He is currently a mentor and supervisor to advanced trainees, PhD students and early career researchers at the Royal Children's Hospital and within PREDICT. He has published >350 peer reviewed publications including in the Lancet, New England Journal of Medicine and BMJ. He is Chief Investigator on a number of National Health and Medical Research Council and Medical Research Futures Fund funded studies. Total grant funding over his career is >$52 million. He is the director of an NHMRC Centre of Research Excellence in Paediatric Emergency Medicine.
Professor Franz Babl is the Group Leader of Emergency Research at the Murdoch Children's Research Institute and the Professor of Paediatric Emergency Medicine at the University of Melbourne. He works as a paediatric emergency physician at The Royal...
Professor Franz Babl is the Group Leader of Emergency Research at the Murdoch Children's Research Institute and the Professor of Paediatric Emergency Medicine at the University of Melbourne. He works as a paediatric emergency physician at The Royal Children's Hospital. He studied in Germany, the United Kingdom and the United States of America and trained in the USA as a paediatrician, emergency physician and infectious diseases physician.

He was the co-founder and founding chair of the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network in Australia and New Zealand, and a current member of the executive committee. This network involves all major tertiary paediatric hospitals in Australia and New Zealand, with an annual census of half a million paediatric presentations. This collaboration is uniquely placed to conduct multicentre trials.

Professor Babl has conducted many collaborative studies with the PREDICT network. He is currently a mentor and supervisor to advanced trainees, PhD students and early career researchers at the Royal Children's Hospital and within PREDICT. He has published >350 peer reviewed publications including in the Lancet, New England Journal of Medicine and BMJ. He is Chief Investigator on a number of National Health and Medical Research Council and Medical Research Futures Fund funded studies. Total grant funding over his career is >$52 million. He is the director of an NHMRC Centre of Research Excellence in Paediatric Emergency Medicine.

Top Publications

  • Stukas, S, Higgins, V, Frndova, H, Gill, J, Hubara, E, Guerguerian, A-M, Boutis, K, Beauchamp, M, Farrell, C, Babl, FE, et al. Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study. The Lancet Child & Adolescent Health 3(8) : 558 -567 2019
    view publication
  • Ibrahim, LF, Babl, FE, Hopper, SM, Bryant, PA. Cellulitis: oral versus intravenous and home versus hospital—what makes clinicians decide?. Archives of Disease in Childhood 105(4) : 413 2019
    view publication
  • Ibrahim, LF, Hopper, SM, Orsini, F, Daley, AJ, Babl, FE, Bryant, PA. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial. The Lancet Infectious Diseases 19(5) : 477 -486 2019
    view publication
  • Parkin, GM, Clarke, C, Takagi, M, Hearps, S, Babl, FE, Davis, GA, Anderson, V, Ignjatovic, V. Plasma Tumor Necrosis Factor Alpha Is a Predictor of Persisting Symptoms Post-Concussion in Children. Journal of Neurotrauma 36(11) : 1768 -1775 2019
    view publication
  • Ibrahim, LF, Hopper, SM, Donath, S, Salvin, B, Babl, FE, Bryant, PA. Development and Validation of a Cellulitis Risk Score: The Melbourne ASSET Score. Pediatrics 143(2) : e20181420 2019
    view publication

Page 1 of 10

Professional activities